A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS)
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 10 Apr 2017
At a glance
- Drugs RNS 60 (Primary) ; RNS 60 (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 06 Apr 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Mar 2018.
- 06 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 29 Jul 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2017.